Bristol-Myers Squibb Co at Goldman Sachs Healthcare Conference Transcript
Terrific. We are just about in time. So let's keep moving and kick off with the next session, Bristol-Myers, I am very excited to have Christian Massacesi, CMO and Chuck Triano, SVP and Head of IR. Welcome, both. Thank you for being here.
Great to be here.
Great to be here.
Questions & Answers
So Christian, I know that there's a lot to talk about, but maybe we can start at 10,000 feet at a high level. We've noted that Bristol has been performing very well from a commercial execution perspective. But I think what investors are most focused on is a very consequential slate of clinical catalysts readouts that are coming up in the fourth quarter and maybe potentially even beyond that in the broader pipeline. And so we're going to try and drill into a lot of the key programs here. But before we do that, I just want to kind of give
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
